null Option on Moderna

MRNA Stock  USD 31.26  0.94  2.92%   
Moderna's latest option contracts expiring on October 17th 2025 are carrying combined implied volatility of 0.65 with a put-to-call open interest ratio of 0.94 over 65 outstanding agreements suggesting investors are buying slightly more calls than puts on contracts expiring on October 17th 2025. The total put volume is at 1.7 K, with calls trading at the volume of 2.6 K. This yields a 0.67 put-to-call volume ratio.

Open Interest Against October 17th 2025 Option Contracts

The chart above shows Moderna's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Moderna's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Moderna's option, there is no secondary market available for investors to trade.

Moderna Maximum Pain Price Across 2025-10-17 Option Contracts

Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Moderna close to expiration to expire worthless. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, Moderna's option sellers may reap the most after selling more options than buying, causing them to expire worthless.

In The Money vs. Out of Money Option Contracts on Moderna

Analyzing Moderna's in-the-money options over time can help investors to take a profitable long position in Moderna regardless of its overall volatility. This is especially true when Moderna's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Moderna's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Moderna's stock while costing only a fraction of its price.
Moderna's stock options are financial instruments that give investors the right to buy or sell shares of Moderna common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Moderna stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Moderna's stock price goes up or down, the stock options follow.
At present, Moderna's Sale Purchase Of Stock is projected to decrease significantly based on the last few years of reporting. The current year's Stock Based Compensation is expected to grow to about 450.4 M, whereas Total Stockholder Equity is forecasted to decline to about 6.5 B.

Moderna In The Money Call Balance

When Moderna's strike price is surpassing the current stock price, the option contract against Moderna stock is said to be in the money. When it comes to buying Moderna's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Moderna are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Moderna Current Options Market Mood

Moderna's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Moderna Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Unfortunately, most Moderna's options investors are not very successful. Moderna's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current Moderna contract

Base on the Rule 16, the options market is currently suggesting that Moderna will have an average daily up or down price movement of about 0.0406% per day over the life of the 2025-10-17 option contract. With Moderna trading at USD 31.26, that is roughly USD 0.0127. If you think that the market is fully incorporating Moderna's daily price movement you should consider buying Moderna options at the current volatility level of 0.65%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Purchasing Moderna options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Moderna calls. Remember, the seller must deliver Moderna stock to the call owner when a call is exercised.

Moderna Option Chain

When Moderna's strike price is surpassing the current stock price, the option contract against Moderna stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Moderna's option chain is a display of a range of information that helps investors for ways to trade options on Moderna. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Moderna. It also shows strike prices and maturity days for a Moderna against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
MRNA251017C00065000177565.00.05 - 0.150.14Out
Call
MRNA251017C0006000047860.00.12 - 0.230.18Out
Call
MRNA251017C00055000128855.00.18 - 0.270.23Out
Call
MRNA251017C00050000169950.00.36 - 0.440.43Out
Call
MRNA251017C00049000149.00.0 - 0.541.08Out
Call
MRNA251017C00048000048.00.0 - 0.610.61Out
Call
MRNA251017C00047000247.00.0 - 0.660.85Out
Call
MRNA251017C0004600023946.00.61 - 0.670.77Out
Call
MRNA251017C00045000709445.00.69 - 0.750.76Out
Call
MRNA251017C000440001344.00.78 - 0.860.86Out
Call
MRNA251017C000430001543.00.88 - 0.941.14Out
Call
MRNA251017C00042000242.01.0 - 1.041.04Out
Call
MRNA251017C00040000977040.01.26 - 1.311.3Out
Call
MRNA251017C0003900016139.01.42 - 1.471.55Out
Call
MRNA251017C0003800022638.01.6 - 1.661.78Out
Call
MRNA251017C0003700033437.01.8 - 1.871.91Out
Call
MRNA251017C0003600088936.02.04 - 2.12.09Out
Call
MRNA251017C00035000990435.02.31 - 2.372.33Out
Call
MRNA251017C0003400025134.02.61 - 2.672.83Out
Call
MRNA251017C0003300024633.02.94 - 3.053.3Out
Call
MRNA251017C000320005832.03.3 - 3.43.83Out
Call
MRNA251017C000310001631.03.75 - 3.853.95Out
Call
MRNA251017C00030000358130.04.2 - 4.34.26In
Call
MRNA251017C00028000628.05.2 - 5.355.19In
Call
MRNA251017C00026000226.06.45 - 6.657.87In
Call
MRNA251017C00025000283225.07.2 - 7.357.45In
Call
MRNA251017C000240001024.07.95 - 8.19.14In
Call
MRNA251017C000225003822.59.0 - 9.310.32In
Call
MRNA251017C0002000010120.011.3 - 11.514.04In
Call
MRNA251017C000175003117.513.65 - 14.1514.65In
Call
MRNA251017C000150004415.016.1 - 16.5516.5In
Call
MRNA251017C000125001112.518.2 - 19.3516.3In
 Put
MRNA251017P00065000165.033.55 - 34.1534.95In
 Put
MRNA251017P00060000060.028.7 - 29.5528.7In
 Put
MRNA251017P000550003355.024.0 - 24.229.45In
 Put
MRNA251017P0005000015150.019.1 - 19.318.44In
 Put
MRNA251017P00049000049.018.1 - 18.3518.1In
 Put
MRNA251017P00048000048.017.15 - 17.3517.15In
 Put
MRNA251017P00047000047.016.25 - 16.416.25In
 Put
MRNA251017P00046000046.015.3 - 15.515.3In
 Put
MRNA251017P0004500020945.014.35 - 14.5515.22In
 Put
MRNA251017P00044000044.013.45 - 13.6512.65In
 Put
MRNA251017P0004000079440.09.9 - 10.059.3In
 Put
MRNA251017P000390006739.09.05 - 9.28.1In
 Put
MRNA251017P000380009538.08.2 - 8.357.4In
 Put
MRNA251017P0003700022737.06.9 - 7.556.7In
 Put
MRNA251017P0003600020036.06.65 - 6.86.2In
 Put
MRNA251017P00035000228135.05.9 - 6.055.4In
 Put
MRNA251017P0003400021834.05.25 - 5.354.8In
 Put
MRNA251017P0003300021233.04.55 - 4.74.45In
 Put
MRNA251017P0003200020632.03.95 - 4.054.0In
 Put
MRNA251017P0003100016931.03.4 - 3.53.5Out
 Put
MRNA251017P00030000884830.02.88 - 2.932.67Out
 Put
MRNA251017P0002900031829.02.4 - 2.462.3Out
 Put
MRNA251017P000280006128.01.94 - 2.31.8Out
 Put
MRNA251017P000270007427.01.59 - 2.191.47Out
 Put
MRNA251017P000260001826.01.25 - 1.31.21Out
 Put
MRNA251017P00025000920825.00.97 - 1.010.9Out
 Put
MRNA251017P000240006924.00.73 - 0.770.75Out
 Put
MRNA251017P00022500504522.50.44 - 0.50.42Out
 Put
MRNA251017P0002100059921.00.22 - 1.290.25Out
 Put
MRNA251017P00020000387920.00.12 - 0.430.22Out
 Put
MRNA251017P00017500202117.50.0 - 0.360.1Out
 Put
MRNA251017P00015000201815.00.05 - 0.180.08Out
 Put
MRNA251017P00012500159812.50.01 - 0.030.02Out

Moderna Total Stockholder Equity

Total Stockholder Equity

6.48 Billion

At present, Moderna's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting.

Moderna Corporate Management

Melanie MBAChief OfficerProfile
Stephane BancelCEO DirectorProfile
Dave JohnsonChief OfficerProfile
Lavina CFASenior RelationsProfile
Noubar AfeyanIndependent CoFounderProfile
Allison MDSenior DevelopmentProfile
When determining whether Moderna offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Moderna's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Moderna Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Moderna Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Moderna. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For information on how to trade Moderna Stock refer to our How to Trade Moderna Stock guide.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Moderna. If investors know Moderna will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Moderna listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.85)
Earnings Share
(8.73)
Revenue Per Share
8.252
Quarterly Revenue Growth
(0.35)
Return On Assets
(0.16)
The market value of Moderna is measured differently than its book value, which is the value of Moderna that is recorded on the company's balance sheet. Investors also form their own opinion of Moderna's value that differs from its market value or its book value, called intrinsic value, which is Moderna's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Moderna's market value can be influenced by many factors that don't directly affect Moderna's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Moderna's value and its price as these two are different measures arrived at by different means. Investors typically determine if Moderna is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Moderna's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.